UCB opens applications for 2027 UCB Myasthenia Gravis Scholarship™
ATLANTA, Nov. 5, 2026 /PRNewswire/ -- UCB, a global biopharmaceutical company, today announced the opening of applications for the third annual UCB U.S. Myasthenia Gravis Scholarship™, supporting individuals impacted by myasthenia gravis (MG), including patients, caregivers, and family...